HomeMy WebLinkAbout1910_Brickhaven_LeachateSamplingResults_Jan2017_DIN27750_20170215
February 15, 2017
City of Sanford (sent via electronic email)
Wastewater Management Facility
P.O. Box 3729
Sanford, NC 27330
Attention: Sarah Jordan – Pretreatment Coordinator
RE: Wastewater Reporting – City of Sanford IUP #000035
Brickhaven Mine Facility, Chatham County, NC
Dear Ms. Jordan:
Attached please find our monthly wastewater quality sampling results for the discharges during the
month of January, 2017. Additionally, we have attached the semi‐annually testing results for 624/625
constituent testing as required by permit. We certify these results as compliant with the IUP
requirements and have attached a copy of the laboratory results for your review and records.
Feel free to contact us with any questions.
Best regards,
Norman E. Divers, III
Engineering & Environmental Director
/ned
Attachments: Monthly Leachate Reporting Worksheet
Semi‐Annual Leachate Reporting Worksheet
Laboratory Results
Cc: Tom Flanagan, Project Director – Charah
Nate Nickerson, Project Manager – Charah
Kyle Hoover, EM – Charah
Jeremey Kerly, EPS II ‐ Charah
Project Files
Pr
o
j
e
c
t
:
Sa
m
p
l
e
Po
i
n
t
:
No
t
e
s
:
In
i
t
i
a
l
Sa
m
p
l
i
n
g
Da
t
e
:
11
/
5
/
2
0
1
5
La
s
t
Sa
m
p
l
i
n
g
Da
t
e
:
10
/
1
8
/
2
0
1
6
Co
n
s
t
i
t
u
e
n
t
Mo
n
i
t
o
r
i
n
g
Sa
m
p
l
i
n
g
Fr
e
q
u
e
n
c
y
Sa
m
p
l
e
Da
t
e
Da
i
l
y
Ma
x
i
m
u
m
Co
n
c
e
n
t
r
a
t
i
o
n
(m
g
/
l
)
Da
i
l
y
Ma
x
i
m
u
m
Li
m
i
t
(lb
s
.
/
d
a
y
)
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
Le
v
e
l
(m
g
/
l
)
Re
q
u
i
r
e
d
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
Level
(m
g
/
l
)
PC
B
10
1
6
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
0
1
0.001
PC
B
12
2
1
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
0
1
0.001
PC
B
12
3
2
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
0
1
0.001
PC
B
12
4
2
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
0
1
0.001
PC
B
12
5
4
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
0
1
0.001
PC
B
12
6
0
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
0
1
0.001
Me
t
h
y
l
e
n
e
Ch
l
o
r
i
d
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Tr
i
c
h
l
o
r
o
f
l
u
o
r
o
m
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
1
‐Di
c
h
l
o
r
o
e
t
h
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
1
‐Di
c
h
l
o
r
o
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Ch
l
o
r
o
f
o
r
m
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Ca
r
b
o
n
Te
t
r
a
c
h
l
o
r
i
d
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
2
‐Di
c
h
l
o
r
o
p
r
o
p
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
1
,
2
‐Tr
i
c
h
l
o
r
o
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Ch
l
o
r
o
b
e
n
z
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Tr
a
n
s
‐1,
2
‐Di
c
h
l
o
r
o
e
t
h
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
2
‐Di
c
h
l
o
r
o
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
1
,
1
‐Tr
i
c
h
l
o
r
o
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Ci
s
‐1,
3
‐Di
c
h
l
o
r
o
p
r
o
p
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Be
n
z
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Tr
a
n
s
‐1,
3
‐Di
c
h
l
o
r
o
p
r
o
p
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Br
o
m
o
f
o
r
m
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
1
,
2
,
2
‐Te
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
To
l
u
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Et
h
y
l
Be
n
z
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Ch
l
o
r
o
m
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Br
o
m
o
m
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Vi
n
y
l
Ch
l
o
r
i
d
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Ch
l
o
r
o
e
t
h
a
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
To
t
a
l
Xy
l
e
n
e
s
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
2
‐Di
c
h
l
o
r
o
b
e
n
z
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,
3
‐Di
c
h
l
o
r
o
b
e
n
z
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
1,4
‐Dic
h
l
o
r
b
e
n
z
e
n
e
1 pe
r
Six
Mo
n
t
h
s
1/
4
/
2
0
1
7
BQ
L
mg
/
l
M&
R
N
/
E
0.
0
1
0
N/E
Ch
a
r
a
h
Pe
r
i
o
d
i
c
Le
a
c
h
a
t
e
Sa
m
p
l
i
n
g
Da
t
a
Sh
e
e
t
Br
i
c
k
h
a
v
e
n
St
r
u
c
t
u
r
a
l
Fil
l
LT
‐01 M&
R
‐
Mo
n
i
t
o
r
an
d
Re
p
o
r
t
N/
A
= No
t
Ap
p
l
i
c
a
b
l
e
An
a
l
y
t
i
c
a
l
Re
s
u
l
t
P
C
B
6
2
4
PC
B
= Po
l
y
c
h
l
o
r
i
n
a
t
e
d
Bip
h
e
n
y
l
m
g
/
L
= mi
l
l
i
g
r
a
m
s
pe
r
Lit
e
r
= pa
r
t
s
pe
r
mil
l
i
o
n
(p
p
m
)
N/
E
‐
No
t
Es
t
a
b
l
i
s
h
e
d
BQ
L
= Be
l
o
w
Qu
a
n
t
i
t
a
t
i
o
n
Lim
i
t
s
2/
1
5
/
2
0
1
7
6:
5
5
AM
Charah, LLC.
Pr
o
j
e
c
t
:
S
a
m
p
l
e
P
o
i
n
t
:
Ce
r
t
i
f
i
e
d
o
r
A
p
p
r
o
v
e
d
B
y
:
Da
t
e
1
Mo
n
t
h
l
y
A
v
e
r
a
g
e
F
l
o
w
:
4
8
,
1
6
6
G
P
D
0.
0
4
8
2
M
G
D
Mo
n
t
h
l
y
P
e
a
k
D
a
i
l
y
F
l
o
w
:
6
0
,
0
0
0
G
P
D
0.
0
6
0
0
MG
D
Co
n
s
t
i
t
u
e
n
t
Da
i
l
y
M
a
x
i
m
u
m
C
o
n
s
t
i
t
u
e
n
t
Co
n
c
e
n
t
r
a
t
i
o
n
(
m
g
/
l
)
Mo
n
t
h
l
y
A
v
e
r
a
g
e
Co
n
s
t
i
t
u
e
n
t
C
o
n
c
e
n
t
r
a
t
i
o
n
(m
g
/
l
)
Mo
n
t
h
l
y
A
v
e
r
a
g
e
Ma
s
s
B
a
s
e
d
L
i
m
i
t
o
n
ac
t
u
a
l
f
l
o
w
1
(l
b
s
.
/
d
a
y
)
Co
m
p
l
i
a
n
t
Di
s
c
h
a
r
g
e
?
1
Pe
r
m
i
t
t
e
d
M
o
n
t
h
l
y
Av
e
r
a
g
e
A
l
l
o
w
a
b
l
e
Ma
s
s
B
a
s
e
d
L
i
m
i
t
(l
b
s
.
/
d
a
y
)
Al
u
m
i
n
u
m
21
.
5
0
0
6.
6
3
8
2.
6
6
6
3
Ye
s
N/
E
An
t
i
m
o
n
y
0.
0
1
0
0
0.
0
0
5
3
0.
0
0
2
1
Ye
s
N/
E
Ar
s
e
n
i
c
0.0
1
7
0
.
0
1
2
0.
0
0
4
7
Ye
s
0.2
4
Ba
r
i
u
m
0.3
8
9
0
.
1
9
0
0.
0
7
6
4
Ye
s
7.2
1
Be
r
y
l
l
i
u
m
0.0
0
2
0
.
0
0
1
0.
0
0
0
3
Ye
s
N/
E
Br
o
m
i
d
e
0.6
4
0
0
.
5
6
9
0.
2
2
8
4
Ye
s
N/
E
Ca
d
m
i
u
m
0.0
0
2
0
.
0
0
1
0.
0
0
0
4
Ye
s
N/
E
Ch
r
o
m
i
u
m
0.0
1
8
0
.
0
0
5
0.
0
0
2
0
Ye
s
0.
0
3
1
Co
p
p
e
r
0.0
3
3
0
.
0
1
1
0.
0
0
4
4
Ye
s
N/
E
Cy
a
n
i
d
e
0.0
1
0
0
.
0
1
0
0.
0
0
4
0
Ye
s
N/
E
Ir
o
n
23
.
3
0
0
5
.
8
2
6
2.
3
4
0
4
Ye
s
N/
E
Le
a
d
0.0
1
4
0
.
0
0
3
0.
0
0
1
2
Ye
s
N/
E
Lo
w
L
e
v
e
l
M
e
r
c
u
r
y
0.
0
0
0
0
1
0
9
0
.
0
0
0
0
0
5
6
0.0
0
0
0
0
2
2
Ye
s
0.
0
0
2
Mo
l
y
b
d
e
n
u
m
0.3
2
2
0
.
2
6
6
0.
1
0
6
8
Ye
s
0.
1
3
4
Ni
c
k
e
l
0.1
2
0
0
.
0
8
4
0.
0
3
3
7
Ye
s
0.
0
5
3
Se
l
e
n
i
u
m
0.0
1
6
0
.
0
0
9
0.
0
0
3
6
Ye
s
0.
2
4
0
Si
l
v
e
r
0.0
0
2
0
.
0
0
1
0.
0
0
0
3
Ye
s
N/
E
St
r
o
n
t
i
u
m
6.0
0
0
5
.
3
0
5
2.
1
3
1
0
Ye
s
N/
E
Zin
c
0.
1
9
6
0
.
0
9
8
0.
0
3
9
2
Ye
s
0.
1
0
3
To
t
a
l
D
i
s
s
o
l
v
e
d
S
o
l
i
d
s
(
T
D
S
)
11
3
0
1
1
1
0
44
5
.
8
9
Ye
s
N/
E
pH
*
7.0
9
|
7
.
8
7
7
.
8
7
*
*
N/
A
Ye
s
N/
E
Am
m
o
n
i
a
0.
1
8
0
0.
1
1
2
0.
0
4
5
0
Ye
s
N/
E
To
t
a
l
S
u
s
p
e
n
d
e
d
S
o
l
i
d
s
(
T
S
S
)
29
5
.
0
0
10
7
.
2
5
43
.
0
8
2
7
Ye
s
N/
E
*
M
i
n
i
m
u
m
a
n
d
M
a
x
i
m
u
m
p
H
v
a
l
u
e
s
s
h
o
w
n
**
M
o
n
t
h
l
y
m
a
x
i
m
u
m
p
H
v
a
l
u
e
s
h
o
w
n
1.
C
o
n
s
i
t
u
e
n
t
m
a
s
s
b
a
s
e
d
l
i
m
i
t
c
a
l
c
u
l
a
t
e
d
o
n
a
v
e
r
a
g
e
d
a
i
l
y
f
l
o
w
d
e
r
i
v
e
d
f
r
o
m
t
o
t
a
l
m
o
n
t
h
l
y
f
l
o
w
d
a
t
a
.
N/
E
=
No
t
E
s
t
a
b
l
i
s
h
e
d
No
n
P
e
r
m
i
t
R
e
q
u
i
r
e
d
C
o
n
s
t
i
t
u
e
n
t
s
5 D
a
y
B
O
D
2.0
0
2.
0
0
0.
8
0
3
4
Ye
s
N/
R
To
t
a
l
P
h
o
s
p
h
o
r
o
u
s
0.0
5
0.
0
5
0.
0
2
0
1
Ye
s
N/
R
Su
l
f
i
d
e
0.0
5
0.
0
5
0.
0
2
0
1
Ye
s
N/
R
N/
R
=
No
t
R
e
q
u
i
r
e
d
f
o
r
I
U
P
P
e
r
m
i
t
#
0
0
0
0
3
5
;
C
o
n
s
t
i
t
u
e
n
t
s
r
e
p
o
r
te
d
t
o
m
e
e
t
P
e
r
m
i
t
C
o
n
d
i
t
i
o
n
P
a
r
t
I
I
N
o
.
4
.
20
1
7
Ch
a
r
a
h
Mo
n
t
h
l
y
L
e
a
c
h
a
t
e
M
o
n
i
t
o
r
i
n
g
S
u
m
m
a
r
y
R
e
p
o
r
t
Br
i
c
k
h
a
v
e
n
S
t
r
u
c
t
u
r
a
l
F
i
l
l
S
i
t
e
LT
-
0
1
2/
1
5
/
2
0
1
7
7:0
2
A
M
Charah, LLC.
Date
1
1/1/2017 - 0.0000 288,000 0.288
1/2/2017 - 0.0000 288,000 0.288
1/3/2017 57,600 0.0576 288,000 0.288
1/4/2017 57,600 0.0576 288,000 0.288
1/5/2017 57,610 0.0576 288,000 0.288
1/6/2017 57,596 0.0576 288,000 0.288
1/7/2017 - 0.0000 288,000 0.288
1/8/2017 - 0.0000 288,000 0.288
1/9/2017 - 0.0000 288,000 0.288
1/10/2017 57,748 0.0577 288,000 0.288
1/11/2017 54,919 0.0549 288,000 0.288
1/12/2017 57,440 0.0574 288,000 0.288
1/13/2017 57,428 0.0574 288,000 0.288
1/14/2017 57,050 0.0571 288,000 0.288
1/15/2017 54,987 0.0550 288,000 0.288
1/16/2017 54,990 0.0550 288,000 0.288
1/17/2017 54,930 0.0549 288,000 0.288
1/18/2017 59,988 0.0600 288,000 0.288
1/19/2017 59,994 0.0600 288,000 0.288
1/20/2017 59,995 0.0600 288,000 0.288
1/21/2017 59,982 0.0600 288,000 0.288
1/22/2017 60,000 0.0600 288,000 0.288
1/23/2017 56,316 0.0563 288,000 0.288
1/24/2017 56,181 0.0562 288,000 0.288
1/25/2017 56,391 0.0564 288,000 0.288
1/26/2017 56,372 0.0564 288,000 0.288
1/27/2017 56,391 0.0564 288,000 0.288
1/28/2017 55,369 0.0554 288,000 0.288
1/29/2017 56,281 0.0563 288,000 0.288
1/30/2017 59,986 0.0600 288,000 0.288
1/31/2017 60,000 0.0600 288,000 0.288
Total:1,493,144 1.4931
Gallons MG
48,166 GPD
0.0482 MGD
0.144 MGD
Notes:MG = Million Gallons
MGD = Million Gallons per Day
Charah Monthly Leachate Flowrate Log Sheet
Project:Brickhaven Structural Fill
Permitted Monthly Average Flowrate:
Sample Point: LT-01
2017
Flowrate
Recorded By
Daily Flow Reading
Monthly Average Flow Rate:
Daily Maximum
Flowrate
GPD MGD GPD MGD
2/15/2017 7:02 AM Charah, LLC.
Pr
o
j
e
c
t
:
S
a
m
p
l
e
P
o
i
n
t
:
Da
t
e
Re
p
o
r
t
i
n
g
W
e
e
k
:
Ja
n
u
a
r
y
No
t
e
s
:
Co
n
s
t
i
t
u
e
n
t
S
a
m
p
l
e
D
a
t
e
J-
Va
l
u
e
?
Da
i
l
y
Ma
x
i
m
u
m
Co
n
c
e
n
t
r
a
t
i
o
n
(m
g
/
l
)
Da
i
l
y
Ma
x
i
m
u
m
Lim
i
t
(l
b
s
.
/
d
a
y
)
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
Le
v
e
l
(
m
g
/
l
)
Re
q
u
i
r
e
d
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
L
e
v
e
l
(m
g
/
l
)
Co
m
p
l
i
a
n
t
An
a
l
y
s
i
s
?
01
/
0
4
/
1
7
1
.
6
1
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
1
.
1
3
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
0
4
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
5
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
1
0
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
8
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
1
2
1
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
1
2
5
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
0
0
4
mg
/
l
*
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
0
3
mg
/
l
*
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
5
8
1
mg
/
l
0.0
2
0
Y
e
s
01
/
0
5
/
1
7
0
.
6
1
0
mg
/
l
0.0
2
0
Yes
01
/
0
4
/
1
7
0
.
0
0
0
7
mg
/
l
*
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
0
7
mg
/
l
*
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
0
1
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
1
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
0
5
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
5
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
<
0
.
0
1
mg
/
l
0.
0
1
Y
e
s
01
/
0
5
/
1
7
<
0
.
0
1
mg
/
l
0.
0
1
Yes
01
/
0
4
/
1
7
0
.
7
8
1
mg
/
l
0.
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
5
5
9
mg
/
l
0.
0
1
Yes
01
/
0
4
/
1
7
0
.
0
0
0
5
mg
/
l
*
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
0
4
mg
/
l
*
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
0
0
0
0
9
0
9
mg
/
l
0.0
0
0
0
0
1
0
Y
e
s
01
/
0
5
/
1
7
0
.
0
0
0
0
1
0
9
mg
/
l
0.0
0
0
0
0
1
0
Yes
01
/
0
4
/
1
7
0
.
2
5
7
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
2
7
3
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
5
6
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
6
2
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
1
5
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
0
1
6
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
0
0
1
mg
/
l
*
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
<
0
.
0
0
1
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
5
.
0
4
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
5
.
2
7
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
0
.
0
8
6
mg
/
l
0.0
0
1
Y
e
s
01
/
0
5
/
1
7
0
.
1
1
3
mg
/
l
0.0
0
1
Yes
01
/
0
4
/
1
7
7
.
0
9
St
d
.
U
n
i
t
s
N/
A
Y
e
s
01
/
0
5
/
1
7
7
.
4
6
St
d
.
U
n
i
t
s
N/
A
Yes
01
/
0
4
/
1
7
<
0
.
1
mg
/
l
0.1
Y
e
s
01
/
0
5
/
1
7
<
0
.
1
mg
/
l
0.1
Yes
01
/
0
4
/
1
7
1
5
.
1
mg
/
l
2.5
Y
e
s
01
/
0
5
/
1
7
1
6
.
5
mg
/
l
2.5
Yes
To
t
a
l
D
i
s
s
o
l
v
e
d
S
o
l
i
d
s
(
T
D
S
)
1 p
e
r
w
e
e
k
01
/
0
4
/
1
7
1
0
8
0
mg
/
l
M
&
R
N
/
E
25
N/
A
N/A
20
1
7
St
r
o
n
t
i
u
m
Zin
c
Co
p
p
e
r
Cy
a
n
i
d
e
Ir
o
n
Le
a
d
Lo
w
L
e
v
e
l
M
e
r
c
u
r
y
Mo
l
y
b
d
e
n
u
m
Al
u
m
i
n
u
m
An
t
i
m
o
n
y
Ar
s
e
n
i
c
Ba
r
i
u
m
Be
r
y
l
l
i
u
m
Br
o
m
i
d
e
Ca
d
m
i
u
m
Ch
r
o
m
i
u
m
An
a
l
y
t
i
c
a
l
R
e
s
u
l
t
0.
0
0
1
1
0.0
0
1
0.0
0
5
0.0
0
2
0.
0
1
Nic
k
e
l
Se
l
e
n
i
u
m
Si
l
v
e
r
M&
R
M&
R
N/
E
N/
E
M&
R
M&
R
M&
R
N/
E
N/
E
N/
E
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
0.0
0
1
0.
0
0
2
4
N/
E
N/
E
N/
E
N/
E
N/
E
N/
E
0.0
0
1
0.
0
0
0
0
0
1
0.0
0
1
0.0
0
5
0.0
0
2
0.0
0
1
0.0
9
4
0.0
0
2
0.0
0
5
0.0
0
5
0.
0
1
0.
0
1
0
1
N/
E
N/
E
N/
E
N/
E
N/
E
N/
E
N/
E
N/
E
N/
E
N/
E
N/
E
M&
R
M&
R
N/
E
M&
R
M&
R
M&
R
M&
R
N/
E
N/
E
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
N/
E
N/
E
We
e
k
l
y
L
e
a
c
h
a
t
e
S
a
m
p
l
i
n
g
D
a
t
a
S
h
e
e
t
Ch
a
r
a
h
LT
-
0
1
We
e
k
1
pH
2 p
e
r
w
e
e
k
6.0
-
1
0
.
5
N
/
E
S
t
d
.
U
n
i
t
s
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
M&
R
-
M
o
n
i
t
o
r
a
n
d
R
e
p
o
r
t
N
/
A
=
N
o
t
A
p
p
l
i
c
a
b
l
e
N/
E
-
N
o
t
E
s
t
a
b
l
i
s
h
e
d
B
Q
L
=
B
e
l
o
w
Q
u
a
n
t
i
t
a
t
i
o
n
L
i
m
i
t
s
Br
i
c
k
h
a
v
e
n
S
t
r
u
c
t
u
r
a
l
F
i
l
l
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
1
Am
m
o
n
i
a
To
t
a
l
S
u
s
p
e
n
d
e
d
S
o
l
i
d
s
(
T
S
S
)
2 p
e
r
w
e
e
k
M&
R
N
/
E
2
.
5
2/
1
5
/
2
0
1
7
7:
0
2
A
M
Charah, LLC.
6
Pr
o
j
e
c
t
:
S
a
m
p
l
e
P
o
i
n
t
:
Da
t
e
Re
p
o
r
t
i
n
g
W
e
e
k
:
1
No
t
e
s
:
Co
n
s
t
i
t
u
e
n
t
Mo
n
i
t
o
r
i
n
g
Sa
m
p
l
i
n
g
Fr
e
q
u
e
n
c
y
S
a
m
p
l
e
D
a
t
e
J-
Va
l
u
e
?
Da
i
l
y
Ma
x
i
m
u
m
Co
n
c
e
n
t
r
a
t
i
o
n
(m
g
/
l
)
Da
i
l
y
Ma
x
i
m
u
m
Li
m
i
t
(lb
s
.
/
d
a
y
)
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
Le
v
e
l
(
m
g
/
l
)
Re
q
u
i
r
e
d
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
L
e
v
e
l
(m
g
/
l
)
Co
m
p
l
i
a
n
t
An
a
l
y
s
i
s
?
01
/
1
1
/
1
7
8
.
8
6
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
5
.
6
5
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
1
0
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
0
5
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
1
7
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
1
2
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
1
8
7
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
2
4
0
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
0
1
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
0
0
8
mg
/
l
*
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
4
5
6
mg
/
l
0.
0
2
0
Yes
01
/
1
2
/
1
7
0
.
5
6
9
mg
/
l
0.
0
2
0
Yes
01
/
1
1
/
1
7
0
.
0
0
1
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
0
1
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
0
3
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
0
4
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
1
5
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
1
1
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
<
0
.
0
1
mg
/
l
0.0
1
Yes
01
/
1
2
/
1
7
<
0
.
0
1
mg
/
l
0.0
1
Yes
01
/
1
1
/
1
7
5
.
5
6
mg
/
l
0.0
1
Yes
01
/
1
2
/
1
7
4
.
8
4
mg
/
l
0.0
1
Yes
01
/
1
1
/
1
7
0
.
0
0
3
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
0
4
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
0
0
0
0
6
1
0
mg
/
l
0.0
0
0
0
0
1
0
Yes
01
/
1
2
/
1
7
0
.
0
0
0
0
0
3
4
6
mg
/
l
0.0
0
0
0
0
1
0
Yes
01
/
1
1
/
1
7
0
.
2
3
4
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
1
7
2
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
7
7
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
8
1
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
0
1
5
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
1
0
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
<
0
.
0
0
1
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
0
0
1
mg
/
l
*
0.
0
0
1
Yes
01
/
1
1
/
1
7
4
.
7
7
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
4
.
6
0
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
0
.
1
0
0
mg
/
l
0.
0
0
1
Yes
01
/
1
2
/
1
7
0
.
0
7
5
mg
/
l
0.
0
0
1
Yes
01
/
1
1
/
1
7
7
.
6
8
St
d
.
U
n
i
t
s
N/
A
Yes
01
/
1
2
/
1
7
7
.
8
7
St
d
.
U
n
i
t
s
N/
A
Yes
01
/
1
1
/
1
7
<
0
.
1
mg
/
l
0.
1
Yes
01
/
1
2
/
1
7
<
0
.
1
mg
/
l
0.
1
Yes
01
/
1
1
/
1
7
1
2
0
mg
/
l
2.
5
Yes
01
/
1
2
/
1
7
2
0
3
mg
/
l
2.
5
Yes
To
t
a
l
D
i
s
s
o
l
v
e
d
S
o
l
i
d
s
(
T
D
S
)
1
p
e
r
w
e
e
k
01
/
1
1
/
1
7
1
1
1
0
mg
/
l
M
&
R
N
/
E
25
N/
A
N/A
We
e
k
2
20
1
7
M&
R
-
M
o
n
i
t
o
r
a
n
d
R
e
p
o
r
t
N
/
A
=
N
o
t
A
p
p
l
i
c
a
b
l
e
N/
E
-
N
o
t
E
s
t
a
b
l
i
s
h
e
d
B
Q
L
=
B
e
l
o
w
Q
u
a
n
t
i
t
a
t
i
o
n
L
i
m
i
t
s
An
a
l
y
t
i
c
a
l
R
e
s
u
l
t
Alu
m
i
n
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
1
An
t
i
m
o
n
y
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Ar
s
e
n
i
c
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Ba
r
i
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
Be
r
y
l
l
i
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
Br
o
m
i
d
e
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
9
4
Ca
d
m
i
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
2
Ch
r
o
m
i
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Le
a
d
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Co
p
p
e
r
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
5
Cy
a
n
i
d
e
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
St
r
o
n
t
i
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Nic
k
e
l
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Se
l
e
n
i
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
Ch
a
r
a
h
We
e
k
l
y
L
e
a
c
h
a
t
e
S
a
m
p
l
i
n
g
D
a
t
a
S
h
e
e
t
Br
i
c
k
h
a
v
e
n
S
t
r
u
c
t
u
r
a
l
F
i
l
l
LT
-
0
1
Si
l
v
e
r
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Lo
w
L
e
v
e
l
M
e
r
c
u
r
y
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
0
0
0
1
Mo
l
y
b
d
e
n
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
1
Ir
o
n
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
0
1
pH
2
p
e
r
w
e
e
k
6.0
-
1
0
.
5
N
/
E
S
t
d
.
U
n
i
t
s
Zin
c
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
4
Am
m
o
n
i
a
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
1
To
t
a
l
S
u
s
p
e
n
d
e
d
S
o
l
i
d
s
(
T
S
S
)
2
p
e
r
w
e
e
k
M&
R
N
/
E
2
.
5
2/
1
5
/
2
0
1
7
7:0
2
A
M
Charah, LLC.
Pr
o
j
e
c
t
:
S
a
m
p
l
e
P
o
i
n
t
:
Da
t
e
Re
p
o
r
t
i
n
g
W
e
e
k
:
1
No
t
e
s
:
Co
n
s
t
i
t
u
e
n
t
Mo
n
i
t
o
r
i
n
g
Sa
m
p
l
i
n
g
Fr
e
q
u
e
n
c
y
S
a
m
p
l
e
D
a
t
e
J-
Va
l
u
e
?
Da
i
l
y
Ma
x
i
m
u
m
Co
n
c
e
n
t
r
a
t
i
o
n
(m
g
/
l
)
Da
i
l
y
Ma
x
i
m
u
m
Li
m
i
t
(lb
s
.
/
d
a
y
)
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
Le
v
e
l
(
m
g
/
l
)
Re
q
u
i
r
e
d
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
L
e
v
e
l
(m
g
/
l
)
Co
m
p
l
i
a
n
t
Analysis?
01
/
1
7
/
1
7
1
.
9
2
mg
/
l
0.
0
0
1
Y
e
s
01
/
1
8
/
1
7
9
.
6
4
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
0
5
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
0
7
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
1
0
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
1
5
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
1
3
6
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
1
3
9
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
0
0
4
mg
/
l
*
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
0
0
6
mg
/
l
*
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
5
5
2
mg
/
l
0.
0
2
0
Yes
01
/
1
8
/
1
7
0
.
5
4
1
mg
/
l
0.
0
2
0
Yes
01
/
1
7
/
1
7
0
.
0
0
0
7
mg
/
l
*
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
0
0
7
mg
/
l
*
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
0
2
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
0
7
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
0
5
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
0
8
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
<
0
.
0
1
mg
/
l
0.0
1
Yes
01
/
1
8
/
1
7
<
0
.
0
1
mg
/
l
0.0
1
Yes
01
/
1
7
/
1
7
1
.
4
6
mg
/
l
0.0
1
Yes
01
/
1
8
/
1
7
6
.
1
4
mg
/
l
0.0
1
Yes
01
/
1
7
/
1
7
0
.
0
0
0
6
mg
/
l
*
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
0
1
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
0
0
0
0
4
1
0
mg
/
l
0.0
0
0
0
0
1
0
Yes
01
/
1
8
/
1
7
0
.
0
0
0
0
0
4
8
2
mg
/
l
0.0
0
0
0
0
1
0
Yes
01
/
1
7
/
1
7
0
.
3
2
2
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
3
1
8
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
1
0
2
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
1
0
4
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
0
5
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
0
4
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
<
0
.
0
0
1
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
<
0
.
0
0
1
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
5
.
9
4
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
6
.
0
0
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
0
.
0
7
3
mg
/
l
0.
0
0
1
Yes
01
/
1
8
/
1
7
0
.
0
9
1
mg
/
l
0.
0
0
1
Yes
01
/
1
7
/
1
7
7
.
1
0
St
d
.
U
n
i
t
s
N/
A
Yes
01
/
1
8
/
1
7
7
.
5
9
St
d
.
U
n
i
t
s
N/
A
Yes
01
/
1
7
/
1
7
<
0
.
1
mg
/
l
0.
1
Yes
01
/
1
8
/
1
7
<
0
.
1
mg
/
l
0.
1
Yes
01
/
1
7
/
1
7
3
6
.
8
mg
/
l
2.
5
Yes
01
/
1
8
/
1
7
6
6
.
6
mg
/
l
2.
5
Yes
To
t
a
l
D
i
s
s
o
l
v
e
d
S
o
l
i
d
s
(
T
D
S
)
1
p
e
r
w
e
e
k
01
/
1
7
/
1
7
1
1
2
0
mg
/
l
M
&
R
N
/
E
25
N/
A
N/A
We
e
k
3
20
1
7
M&
R
-
M
o
n
i
t
o
r
a
n
d
R
e
p
o
r
t
N
/
A
=
N
o
t
A
p
p
l
i
c
a
b
l
e
N/
E
-
N
o
t
E
s
t
a
b
l
i
s
h
e
d
B
Q
L
=
B
e
l
o
w
Q
u
a
n
t
i
t
a
t
i
o
n
L
i
m
i
t
s
An
a
l
y
t
i
c
a
l
R
e
s
u
l
t
Al
u
m
i
n
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
1
An
t
i
m
o
n
y
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Ar
s
e
n
i
c
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Ba
r
i
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
Be
r
y
l
l
i
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
Br
o
m
i
d
e
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
9
4
Ca
d
m
i
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
2
Ch
r
o
m
i
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Le
a
d
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Co
p
p
e
r
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
5
Cy
a
n
i
d
e
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
St
r
o
n
t
i
u
m
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Nic
k
e
l
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Se
l
e
n
i
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
Ch
a
r
a
h
We
e
k
l
y
L
e
a
c
h
a
t
e
S
a
m
p
l
i
n
g
D
a
t
a
S
h
e
e
t
Br
i
c
k
h
a
v
e
n
S
t
r
u
c
t
u
r
a
l
F
i
l
l
LT
-
0
1
Sil
v
e
r
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Lo
w
L
e
v
e
l
M
e
r
c
u
r
y
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
0
0
0
1
Mo
l
y
b
d
e
n
u
m
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
1
Ir
o
n
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
0
1
pH
2
p
e
r
w
e
e
k
6.0
-
1
0
.
5
N
/
E
S
t
d
.
U
n
i
t
s
Zin
c
2
p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
4
Am
m
o
n
i
a
2
p
e
r
w
e
e
k
M&
R
N
/
E
0
.
1
To
t
a
l
S
u
s
p
e
n
d
e
d
S
o
l
i
d
s
(
T
S
S
)
2
p
e
r
w
e
e
k
M&
R
N
/
E
2
.
5
2/
1
5
/
2
0
1
7
7:0
2
A
M
Charah, LLC.
Pro
j
e
c
t
:
S
a
m
p
l
e
P
o
i
n
t
:
Da
t
e
Re
p
o
r
t
i
n
g
W
e
e
k
:
1
No
t
e
s
:
Co
n
s
t
i
t
u
e
n
t
Mo
n
i
t
o
r
i
n
g
Sa
m
p
l
i
n
g
Fr
e
q
u
e
n
c
y
S
a
m
p
l
e
D
a
t
e
J-
Va
l
u
e
?
Da
i
l
y
Ma
x
i
m
u
m
Co
n
c
e
n
t
r
a
t
i
o
n
(m
g
/
l
)
Da
i
l
y
Ma
x
i
m
u
m
Lim
i
t
(lb
s
.
/
d
a
y
)
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
Le
v
e
l
(
m
g
/
l
)
Re
q
u
i
r
e
d
La
b
o
r
a
t
o
r
y
De
t
e
c
t
i
o
n
L
e
v
e
l
(m
g
/
l
)
Co
m
p
l
i
a
n
t
An
a
l
y
s
i
s
?
01
/
2
4
/
1
7
2
1
.
5
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
2
.
7
9
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
0
2
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
4
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
1
5
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
7
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
3
8
9
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
1
8
5
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
0
2
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
0
2
mg
/
l
*
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
6
0
0
mg
/
l
0.0
2
0
Y
e
s
01
/
2
5
/
1
7
0
.
6
4
0
mg
/
l
0.0
2
0
Ye
s
01
/
2
4
/
1
7
0
.
0
0
2
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
0
6
mg
/
l
*
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
1
8
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
3
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
3
3
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
5
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
<
0
.
0
1
mg
/
l
0.0
1
Y
e
s
01
/
2
5
/
1
7
<
0
.
0
1
mg
/
l
0.0
1
Ye
s
01
/
2
4
/
1
7
2
3
.
3
mg
/
l
0.0
1
Y
e
s
01
/
2
5
/
1
7
3
.
9
7
mg
/
l
0.0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
1
4
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
1
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
0
0
0
0
2
0
4
mg
/
l
0.
0
0
0
0
0
1
0
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
0
0
0
4
0
8
mg
/
l
0.
0
0
0
0
0
1
0
Ye
s
01
/
2
4
/
1
7
0
.
2
4
1
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
3
1
0
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
1
2
0
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
6
9
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
0
4
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
3
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
0
0
0
1
mg
/
l
*
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
0
2
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
5
.
4
2
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
5
.
4
0
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
0
.
1
9
6
mg
/
l
0.0
0
1
Y
e
s
01
/
2
5
/
1
7
0
.
0
4
7
mg
/
l
0.0
0
1
Ye
s
01
/
2
4
/
1
7
7
.
2
9
St
d
.
U
n
i
t
s
N/
A
Y
e
s
01
/
2
5
/
1
7
7
.
3
4
St
d
.
U
n
i
t
s
N/
A
Ye
s
01
/
2
4
/
1
7
0
.
1
8
0
mg
/
l
0.
1
Y
e
s
01
/
2
5
/
1
7
0
.
1
1
6
mg
/
l
0.
1
Ye
s
01
/
2
4
/
1
7
2
9
5
mg
/
l
2.
5
Y
e
s
01
/
2
5
/
1
7
1
0
5
mg
/
l
2.
5
Ye
s
To
t
a
l
D
i
s
s
o
l
v
e
d
S
o
l
i
d
s
(
T
D
S
)
1 p
e
r
w
e
e
k
01
/
2
4
/
1
7
1
1
3
0
mg
/
l
M
&
R
N
/
E
25
N/
A
N/
A
No
n
P
e
r
m
i
t
R
e
q
u
i
r
e
d
C
o
n
s
t
i
t
u
e
n
t
s
01
/
2
4
/
1
7
<
2
mg
/
l
01
/
2
5
/
1
7
<
2
mg
/
l
01
/
2
4
/
1
7
<
0
.
0
5
mg
/
l
01
/
2
5
/
1
7
0
.
0
7
7
mg
/
l
01
/
2
4
/
1
7
<
0
.
0
5
mg
/
l
1/
2
5
/
2
0
1
7
<
0.0
5
mg
/
l
N/
R
N/
R
N/
R
N/
R
N/
R
N/
R
2 0.0
5
0.0
5
N/
R
N/
R
N/
R
5 D
a
y
B
O
D
To
t
a
l
P
h
o
s
p
h
o
r
u
s
Su
l
f
i
d
e
N/
R
N/
R
N/
R
M&
R
M&
R
M&
RWe
e
k
4
20
1
7
M&
R
-
M
o
n
i
t
o
r
a
n
d
R
e
p
o
r
t
N
/
A
=
N
o
t
A
p
p
l
i
c
a
b
l
e
N
/
R
=
N
o
t
R
e
q
u
ir
e
d
f
o
r
P
e
r
m
i
t
C
o
m
p
l
i
a
n
c
e
N/E
-
N
o
t
E
s
t
a
b
l
i
s
h
e
d
B
Q
L
=
B
e
l
o
w
Q
u
a
n
t
i
t
a
t
i
o
n
L
i
m
i
t
s
An
a
l
y
t
i
c
a
l
R
e
s
u
l
t
Al
u
m
i
n
u
m
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
1
An
t
i
m
o
n
y
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Ar
s
e
n
i
c
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Ba
r
i
u
m
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
Be
r
y
l
l
i
u
m
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
Br
o
m
i
d
e
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
9
4
Ca
d
m
i
u
m
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
2
Ch
r
o
m
i
u
m
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Le
a
d
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Co
p
p
e
r
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
5
Cy
a
n
i
d
e
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
St
r
o
n
t
i
u
m
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Ni
c
k
e
l
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
5
Se
l
e
n
i
u
m
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
Ch
a
r
a
h
We
e
k
l
y
L
e
a
c
h
a
t
e
S
a
m
p
l
i
n
g
D
a
t
a
S
h
e
e
t
Br
i
c
k
h
a
v
e
n
S
t
r
u
c
t
u
r
a
l
F
i
l
l
LT
-
0
1
Sil
v
e
r
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
0
1
Lo
w
L
e
v
e
l
M
e
r
c
u
r
y
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
0
0
0
1
Mo
l
y
b
d
e
n
u
m
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
1
Ir
o
n
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
0
1
0
1
pH
2 p
e
r
w
e
e
k
6.0
-
1
0
.
5
N
/
E
S
t
d
.
U
n
i
t
s
Zi
n
c
2 p
e
r
w
e
e
k
N/
E
N
/
E
0
.
0
0
2
4
Am
m
o
n
i
a
2 p
e
r
w
e
e
k
M&
R
N
/
E
0
.
1
To
t
a
l
S
u
s
p
e
n
d
e
d
S
o
l
i
d
s
(
T
S
S
)
2 p
e
r
w
e
e
k
M&
R
N
/
E
2
.
5
2/
1
5
/
2
0
1
7
7:
0
2
A
M
Charah, LLC.